The cost effectiveness of opportunistic chlamydia screening in England: Commentary

Sexually Transmitted Infections

Volumn 83, Issue 4, 2007, Pages 275-

  Adams, Elisabeth J ^a   Edmunds, W John ^a   Turner, Katherine M E ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIASIS; COST EFFECTIVENESS ANALYSIS; DISEASE CARRIER; DISEASE COURSE; ECTOPIC PREGNANCY; HEALTH PROGRAM; NOTE; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SCREENING; SENSITIVITY ANALYSIS; TREATMENT OUTCOME;

EID: 34547758483     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2006.024364     Document Type: Note

References (4)

1. National Institute for Clinical Excellence (NICE). Guide to the methods of technology appraisal. London: NICE, 2004, http://www.nice.org.uk (accessed 20 June 2007).
2. Adams EJ, Turner KM, Edmunds WJ. The cost-effectiveness of opportunistic chlamydia screening in England. Sex Transm Infect 2007;83:267-74.
3. Drummond M, Sculpher M, Torrence G, et al. Methods for the economic evaluation of health care programmes, 3rd ed. Oxford: Oxford University Press, 2005.
4. Low N, McCarthy A, Macleod J, et al. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection Health Technology Assessment, 2007. Report No. 11(8).